Results 91 to 100 of about 51,875 (217)

Rifampin monotherapy for multidrug-resistant Chryseobacterium indologenes meningitis unresponsive to trimethoprim-sulfamethoxazole: a case report and review of the literature

open access: yesFrontiers in Medicine
Multidrug-resistant (MDR) Chryseobacterium indologenes is an emerging pathogen causing challenging central nervous system (CNS) infections, for which there are no standardized treatment guidelines.
Dongchuan Shao   +7 more
doaj   +1 more source

Prevalencia de la resistencia de Mycobacterium tuberculosis a quinolonas y fármacos inyectables en Colombia, 2012-2013

open access: yesBiomédica: revista del Instituto Nacional de Salud, 2017
Introducción. La tuberculosis es un problema de salud pública a nivel mundial. En 2014, la Organización Mundial de la Salud estimó que se habían presentado 9,6 millones de casos nuevos y 480.000 multirresistentes.
Claudia Llerena   +3 more
doaj   +1 more source

Rifampin susceptibility testing by Xpert MTB/RIF and phenotypic DST.

open access: yes, 2015
Sensitivity- 94.5% (88.6–97.4)Specificity- 97.7% (95.4–98.9)Positive Predictive Value- 93.6% (87.5–96.9)Negative Predictive Value- 98.0% (95.8–99.1)Data are presented as whole numbers.
Mikashmi Kohli (817879)   +7 more
core   +1 more source

Subgroup analyses: Impact of adjunctive rifampin on SAB mortality.

open access: yes, 2020
Subgroup analyses: Impact of adjunctive rifampin on SAB mortality.
Huan Ma (713125)   +5 more
core   +1 more source

Antimalarial effects of rifampin in Plasmodium vivax malaria.

open access: yes, 2016
The antimalarial effects of rifampin in 60 adults with Plasmodium vivax malaria were assessed. There were three treatment groups: rifampin (20 and 15 mg/kg of body weight per day for 1 and 4 days, respectively; n = 5); rifampin followed by primaquine (15

core   +1 more source

Fast parallel quantification of dual drug systems via UV-VIS spectrometry – a case study with antibiotic substances

open access: yesCurrent Directions in Biomedical Engineering, 2017
Implant-based drug delivery necessitates a rigorous quantitative assessment and quality control of the drug release behavior. In this context, a fast simultaneous UV-VIS spectrometer quantification method was developed for an antibiotic dual drug system.
Eickner Thomas   +5 more
doaj   +1 more source

Fluorescent Protein Expressing Rickettsia buchneri and Rickettsia peacockii for Tracking Symbiont-Tick Cell Interactions

open access: yesVeterinary Sciences, 2016
Rickettsiae of indeterminate pathogenicity are widely associated with ticks. The presence of these endosymbionts can confound a One Health approach to combatting tick-borne diseases.
Timothy J. Kurtti   +3 more
doaj   +1 more source

Treatment with Linezolid or Vancomycin in Combination with Rifampin Is Effective in an Animal Model of Methicillin-Resistant Staphylococcus aureus Foreign Body Osteomyelitis

open access: yes, 2011
Rifampin monotherapy was compared to the combination of linezolid or vancomycin with rifampin in an experimental rat model of methicillin-resistant Staphylococcus aureus (MRSA) chronic foreign body osteomyelitis.
Robin Patel   +7 more
core   +1 more source

Rifampin in Experimental Endocarditis Due to Staphylococcus aureus in Rabbits [PDF]

open access: yes, 2017
Rifampin possesses unique activity against Staphylococcus aureus. It is the most active antistaphylococcal antibiotic currently available and has been shown to be particularly effective in eradicating S.
Sande, Merle A.   +2 more
core  

Rifabutin MIC distribution stratified among conventional rifampin-susceptible and rifampin-resistant isolates.

open access: yes, 2015
Conventional rifampin susceptible by APM (agar proportion method) critical concentration (MIC≤1.0 μg/ml) and resistance (MIC >1.0 μg/ml). Rifabutin critical concentration = 0.5 μg/ml; susceptible (2.0 μg/ml).
Jean Gratz (412093)   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy